Scientifically proven to help protect memory function.

What makes VIVIMIND™ a new generation memory protection solution? Putting it simply, there is no comparable product in the marketplace today.

VIVIMIND™ is different from other natural health solutions because it is:

• Supported by over 15 years of combined rigorous scientific research including clinical testing with over 2,000 individuals¹.
• The first nutraceutical to undergo such in-depth evaluation in large state-of-the-art clinical trials in the field of cognition.

The result of this research and testing is an innovative, evidence-based, natural solution that is proven to protect memory function based on the naturally occurring ingredient, homotaurine, found in seaweed.

How VIVIMIND™ works

As we age, certain brain regions start to shrink. This shrinkage reflects loss of brain cells. One brain region where brain cell loss occurs is the hippocampus, which is a brain region responsible for learning and memory. Indeed, shrinkage of the hippocampus has been associated with problems in learning and memory. VIVIMIND™ can help reduce the loss of brain volume of this very important region of the brain.

Breakthrough clinical results.

Over 18 months Homotaurine reduces the loss of hippocampal volume by 68% compared to placebo

A major groundbreaking study performed in Canada and the United States using brain scans (magnetic resonance imaging (MRI)), showed that homotaurine, the active ingredient in VIVIMIND™, can protect the hippocampus, the portion of the brain associated with a person's ability to learn and remember, by showing that homotaurine reduces the loss of volume by 68 per cent when compared to placebo (like a sugar pill)².

Homotaurine showed a 33% better result in cognitive performance tests (ADAS-cog) vs. placebo at 12 months

Individuals taking VIVIMIND™ also performed better on tests of memory and thinking compared with individuals taking placebo. VIVIMIND™ was found to improve cognitive performance by 33% versus the placebo (like a sugar pill)².

Sign up now to receive email updates on product news and special offers from OVOS Natural Health.

 

¹North American and European phase 3 clinical trials – data on file BELLUS Health.
²Post-hoc analysis of a 78-week Phase III North American study in 1052 mild-to-moderate Alzheimer’s disease patients 50 and older.